425 related articles for article (PubMed ID: 37443082)
1. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
[TBL] [Abstract][Full Text] [Related]
2. Androgen-induced gut dysbiosis disrupts glucolipid metabolism and endocrinal functions in polycystic ovary syndrome.
Han Q; Wang J; Li W; Chen ZJ; Du Y
Microbiome; 2021 May; 9(1):101. PubMed ID: 33957990
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells.
Huang J; Chen P; Xiang Y; Liang Q; Wu T; Liu J; Zeng Y; Zeng H; Liang X; Zhou C
Int Immunopharmacol; 2022 Jun; 107():108717. PubMed ID: 35334358
[TBL] [Abstract][Full Text] [Related]
4. Effects of dehydroepiandrosterone alone or in combination with a high-fat diet and antibiotic cocktail on the heterogeneous phenotypes of PCOS mouse models by regulating gut microbiota.
Wang X; Gu L; Zhang Y; Xiong C; Peng Y; Ding X
Front Endocrinol (Lausanne); 2022; 13():1030151. PubMed ID: 36619569
[TBL] [Abstract][Full Text] [Related]
5. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
6. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.
Xue J; Li X; Liu P; Li K; Sha L; Yang X; Zhu L; Wang Z; Dong Y; Zhang L; Lei H; Zhang X; Dong X; Wang H
Endocr J; 2019 Oct; 66(10):859-870. PubMed ID: 31270279
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic effect of interleukin-22 in high androgen-induced polycystic ovary syndrome.
Qi X; Yun C; Liao B; Qiao J; Pang Y
J Endocrinol; 2020 May; 245(2):281-289. PubMed ID: 32163914
[TBL] [Abstract][Full Text] [Related]
8.
Luo M; Chen Y; Pan X; Chen H; Fan L; Wen Y
Front Immunol; 2023; 14():1137089. PubMed ID: 37275915
[TBL] [Abstract][Full Text] [Related]
9. Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway.
Guan HR; Li B; Zhang ZH; Wu HS; Wang N; Chen XF; Zhou CL; Bian XR; Li L; Xu WF; He XL; Dong YJ; Jiang NH; Su J; Lv GY; Chen SH
J Ethnopharmacol; 2024 Sep; 331():118274. PubMed ID: 38697410
[TBL] [Abstract][Full Text] [Related]
10. Effects of Bu Shen Hua Zhuo formula on the LPS/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome.
Wang Y; Xiao H; Liu Y; Tong Q; Yu Y; Qi B; Bu X; Pan T; Xing Y
Front Endocrinol (Lausanne); 2022; 13():891297. PubMed ID: 36017323
[TBL] [Abstract][Full Text] [Related]
11. Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction.
Li T; Zhang T; Gao H; Liu R; Gu M; Yang Y; Cui T; Lu Z; Yin C
Redox Biol; 2021 May; 41():101886. PubMed ID: 33592539
[TBL] [Abstract][Full Text] [Related]
12. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial.
Phelan N; O'Connor A; Kyaw Tun T; Correia N; Boran G; Roche HM; Gibney J
Am J Clin Nutr; 2011 Mar; 93(3):652-62. PubMed ID: 21270384
[TBL] [Abstract][Full Text] [Related]
13. Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones-Microbiota-Inflammation Axis in Rats.
Wang T; Sha L; Li Y; Zhu L; Wang Z; Li K; Lu H; Bao T; Guo L; Zhang X; Wang H
Front Endocrinol (Lausanne); 2020; 11():284. PubMed ID: 32670195
[TBL] [Abstract][Full Text] [Related]
14. Astragalus polysaccharide alleviates polycystic ovary syndrome by reducing insulin resistance and oxidative stress and increasing the diversity of gut microbiota.
Li R; Hu R; Huang Y; Li D; Ma X; Yang Y
Endocrine; 2024 Mar; 83(3):783-797. PubMed ID: 37824046
[TBL] [Abstract][Full Text] [Related]
15. Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota.
Zhang F; Ma T; Tong X; Liu Y; Cui P; Xu X; Shi J; Hu W; Lu W; Pei Z; Xu M; Li X; Xu C; Feng Y
Acupunct Med; 2022 Aug; 40(4):347-359. PubMed ID: 34892981
[TBL] [Abstract][Full Text] [Related]
16. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome.
Qi X; Yun C; Sun L; Xia J; Wu Q; Wang Y; Wang L; Zhang Y; Liang X; Wang L; Gonzalez FJ; Patterson AD; Liu H; Mu L; Zhou Z; Zhao Y; Li R; Liu P; Zhong C; Pang Y; Jiang C; Qiao J
Nat Med; 2019 Aug; 25(8):1225-1233. PubMed ID: 31332392
[TBL] [Abstract][Full Text] [Related]
18. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
Yurtdaş G; Akdevelioğlu Y
J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications.
Sun Y; Gao S; Ye C; Zhao W
Front Cell Infect Microbiol; 2023; 13():1142041. PubMed ID: 36909735
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and mechanism of Angelica sinensis (Oliv.) Diels root aqueous extract based on RNA sequencing and 16S rDNA sequencing in alleviating polycystic ovary syndrome.
Gao Y; Mo S; Cao H; Zhi Y; Ma X; Huang Z; Li B; Wu J; Zhang K; Jin L
Phytomedicine; 2023 Nov; 120():155013. PubMed ID: 37639812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
